Levels of the immune signaling molecule interleukin-21 (IL-21) and the cells that produce the protein were elevated in the blood…
Articles by Lindsey Shapiro, PhD
Despite being in clinical remission based on physician evaluation, many people with ANCA-associated vasculitis (AAV) report experiencing ongoing…
Limited exposure to ultraviolet (UV) light and related drops in vitamin D levels — particularly over the winter months —…
Undetectable blood levels of ANCAs within six months of remission induction treatment were associated with a lower risk of relapses…
ANCA-associated vasculitis (AAV) emerged as a side effect of levamisole given for years to treat a 15-year-old boy with…
Tavneos (avacopan) reduced respiratory, ear, nose, and throat (ENT) involvement among people with ANCA-associated vasculitis (AAV), but did…
Rituximab treatment led to rates of remission and relapse prevention in Mexican patients with ANCA-associated vasculitis (AAV) that were…
People with rheumatoid arthritis (RA) who also have ANCA-associated vasculitis (AAV) are more likely to develop signs of kidney…
Prolonged low levels of immunoglobulin antibodies as a result of rituximab treatment did not increase the likelihood of serious infections…
Infliximab successfully led to the remission of respiratory symptoms in a 15-year-old boy with steroid-resistant granulomatosis with polyangiitis (GPA),…